Expanding MRD testing to more patients with colorectal cancer

Giving clinicians more Latitude™ with MRD testing

Latitude™ is a tissue-free, blood-based, residual disease test (MRD) that delivers fast and reliable results without the need for tumor tissue. It is built on Natera’s MRD expertise and offers high concordance with Signatera™ in comparative analysis, built using a targeted panel composed of differentially methylated regions specifically for colorectal cancer (CRC).

When to use Latitude™

When Signatera™ cannot be performed due to tissue limitations, reflex to Latitude™ with the sample on hand to ensure patients still receive MRD results. We will continue to try and build Signatera™ if possible, but if not the patient can continue with Latitude™ for serial testing.
When tissue isn’t available, Latitude™ offers a reliable tissue-free MRD solution.
When clinicians need answers fast, Latitude™ and Signatera™ can be ordered at the same time. To enable time for critical adjuvant treatment decisions.

AVAILABLE MID SUMMER

Be the first to know when Latitude™ is available

First Name *

Last Name *

Email Address *

Phone *

Zip Code *

Country *

I am a *

Company

Comments

Natera Honey Pot

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time. By submitting your information you are agreeing to Natera's terms of use and privacy policy.